Infection Control Market to Reach $38.61 Bn, Globally, by 2028 at 3.0% CAGR: Allied Market Research
PORTLAND, Ore., July 8, 2021 /PRNewswire/ -- Allied Market Research published a report, titled, "Infection Control Market by Product & Service (Sterilization, Cleaning & Disinfection Products, Protective Barriers, and Endoscope Reprocessing Products) and End User (Hospitals & Clinics, Pharmaceutical & Medical Device Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2028." According to the report published by Allied Market Research, the global infection control market was pegged at $32.61 billion in 2020 and is estimated to hit $38.61 billion by 2028, registering a CAGR of 3.0% from 2021 to 2028.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/7818
Drivers, restrains, and opportunities-
Rise in incidence of hospital-acquired infections (HAIs), upsurge in likelihood of epidemic or pandemic outbreaks, increase in geriatric population, surge in incidence of chronic diseases, and
growing usage of E-beam sterilization fuel the global infection control market. On the other hand, adverse effects of chemical disinfectants restrain the growth to some extent. However, several growth opportunities in emerging markets have proven to be beneficial for the market growth.
- Increase in usage of medical nonwoven products and gloves during the pandemic has driven the global infection control market.
- This trend is most likely to continue post-pandemic as well, since there would be a steep hike in the use of different types of products and services to control infections such as sterilization, cleaning & disinfection products, protective barriers, endoscope reprocessing merchandises, etc.
The protective barriers segment to dominate by 2028-
On the basis of product & service, the protective barriers segment held more than three-fourths of the global infection control market share in 2020, and is expected to lead the trail by the end of 2028. Rise in outsourcing of sterilization services, re-introduction of ethylene oxide sterilization, and increase in the incidence of chronic diseases, such as cancer, diabetes, and other autoimmune diseases fuel the growth of the segment. The sterilization segment, on the other hand, would cite the fastest CAGR of 4.3% during the forecast period. Surge in public awareness toward personal hygiene, increase in number of surgeries, and rise in adoption of medical nonwovens, such as face masks, surgical drapes, and gowns drive the segment growth.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/7818
The hospitals & clinics segment to maintain the dominant share-
On the basis of end user, the hospitals & clinics segment accounted for nearly half of the global infection control market revenue in 2020, and is projected to rule the roost by the end of 2028. This is attributed to the fact that hospitals & clinics are showing growing inclination toward infection control products. At the same time, the pharmaceutical & medical device companies segment would manifest the fastest CAGR of 3.6% from 2021 to 2028. This is because cleaning, disinfection, decontamination, and sterilization processes in the pharmaceutical companies are validated and routinely monitored by the infection control departments.
North America garnered the major share in 2020-
On the basis of region, North America garnered the highest share in 2020, garnering more than one-third of the global infection control market, owing to increase in need for infection control to minimize the prevalence of HAIs, rise in adoption of sterilization and disinfection products along with contract sterilization services, surge in the geriatric population, availability of advanced healthcare facilities with trained medical professionals, and upsurge in number of R&D activities to develop novel infection control products in the continent. However, the region across Asia-Pacific would grow at the fastest CAGR of 4.3% throughout the forecast period. This is owing to increase in incidences of hospital-acquired infections in emerging economies, due to rise in adoption of sterilization and disinfection equipment, development of the R&D sector, increase in healthcare reforms, and technological advancements in medical device manufacturing in the province.
Key players in the industry-
- Ecolab Inc.
- MMM Group
- Fortive (Advanced Sterilization Products)
- Steris Plc (Cantel Medical Corporation)
- Belimed AG
- Getinge AB
- Matachana Group
- Miele Group
- 3M Company
- Sotera Health Llc
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
SOURCE Allied Market Research
Upcoming Life Sciences Events
- September 2021
- Vilnius: Life Sciences Baltics
- BioPharm America™ 2021
- Online & Oxford: BioForward 2021